Science, Computers & Technology Civil Procedure Administrative Agency

Patents Patent Trial and Appeal Board Inter Partes Review (IPR) Proceeding Appeals Patent Litigation Patent Infringement Pharmaceutical Industry Pharmaceutical Patents FDA USPTO Claim Construction Obviousness SCOTUS Patent-Eligible Subject Matter Prior Art America Invents Act Biosimilars BPCIA Broadest Reasonable Interpretation Standard Prescription Drugs Administrative Procedure Act Patent Invalidity CLS Bank v Alice Corp Generic Drugs Section 101 Amgen ANDA Popular Sandoz v Amgen Preliminary Injunctions Abstract Ideas Cuozzo Speed Technologies v Lee Orphan Drugs Section 340B Covered Business Method Patents FTC ITC Standard of Review HHS Medical Devices Standing Summary Judgment Drones EPA Final Written Decisions Hatch-Waxman Remand Reversal Unmanned Aircraft Systems Vacated Healthcare Judicial Review Jurisdiction Motion to Amend Patent Applications Sandoz Software Patents Affordable Care Act Cuozzo Speed Technologies Dismissals Federal Aviation Administration (FAA) Patent Dance Preemption Commercial Marketing Evidence FDA Approval FDCA Patent Validity Section 337 Trademarks ALJ Biologics Burden of Proof Computer-Related Inventions EU Infringement Manufacturers Pesticides Reaffirmation Registration Requirement Software Technology Sector Trademark Trial and Appeal Board Administrative Proceedings Airspace B&B Hardware v Hargis Industries Chevron Deference Corporate Counsel Data Protection Data Security Doctrine of Equivalents Due Process Estoppel Intellectual Property Litigation Intellectual Property Protection Issue Preclusion LabMD Notice Requirements On-Sale Bar Patent Reform Apotex Attorney's Fees Covered Business Method Proceedings Enfish v Microsoft Ex Partes Reexamination Expert Testimony FTC Act HRSA Induced Infringement Motion to Dismiss Non-Appealable Decisions Novartis Oral Argument Patent Term Adjustment Patent-in-Suit Personal Jurisdiction Personally Identifiable Information PHRMA Post-Grant Review Preponderance of the Evidence Sanctions Subject Matter Jurisdiction Trade Secrets Willful Infringement Written Descriptions Administrative Appeals Anticipation Apple Canada Data Breach Declaratory Judgments Discovery Enforcement Actions Enhanced Damages FFDCA Imports Inequitable Conduct Inventors Labeling Life Sciences Likelihood of Confusion Microsoft Misappropriation Patent Ownership Patent Prosecution Permanent Injunctions Petition for Writ of Certiorari Safe Harbors Stem cells Substantial Evidence Standard Trademark Infringement Abuse of Discretion Administrative Authority Antitrust Litigation Biotechnology Burden-Shifting CAFC Collateral Estoppel Cybersecurity Defend Trade Secrets Act (DTSA) Dispute Resolution En Banc Review Enforcement False Claims Act (FCA) FCC Final Judgment First Amendment Halo v Pulse Health Care Providers Hospitals Inter Partes Reexamination Likelihood of Success Mayo v. Prometheus Medtronic Misleading Statements Notice and Comment Off-Label Promotion Off-Label Use Orange Book State and Local Government Venue Writ of Mandamus Wyndham Young Lawyers 35 U.S.C. § 284 aBLA Amarin Bascom Global v AT&T Mobility Certiorari Citizen Petitions Classen Immunotherapies Confidential Information Constitutional Challenges Contributory Infringement Copyright Infringement Counterclaims Covered Entities Damages Divided Infringement DNA DOJ Elan Pharmaceuticals Endangered Species Act (ESA) Expert Witness Federal Register FIFRA Free Speech Google Hana Financial v Hana Bank Indefiniteness IP License Laches Litigation Strategies Lost Profits McRo v Bandai Namco Means-Plus-Function Noninfringement Open Internet Rules Otsuka Pharmaceutical Patent Exhaustion Petition For Rehearing Prevailing Party Product Labels Request for Continued Examination Rulemaking Process Section 102 Statute of Limitations Statutory Authority Stays Tacking Tariff Act of 1930 Teva Pharmaceuticals Trademark Registration Universities 510(k) RTA Administrative Procedure Admissible Evidence Antitrust Provisions Appellate Review Apple v Samsung Arbitrary and Capricious Ariosa Article III Assignor Estoppel AstraZeneca Australia Bayer Biofuel Broadband Burden of Persuasion Burden of Production CA Supreme Court Case Consolidation CETA Chemicals Claim Amendments Class Action Clear and Convincing Evidence Clear Error Standard Colleges Commercial Success Communications Act 2003 Concurrent Litigation Continuation Applications Copyright Covidien DaimlerAG Data Privacy De Novo Standard of Review Declaration DHS Diagnostic Method Digital Goods Disclosure Disgorgement Doctrine of Prosecution Disclaimer ECHA Electronic Communications Electronics Equitable Estoppel Ethicon Examiners Exhaustion Doctrine Federal Rules of Civil Procedure Final Rules Garmin International General Motors Graham Factors Hackers Health Canada Human Genes Incorporation by Reference Indirect Infringement Inducements Injunctions Injunctive Relief Injury-in-Fact Innovation Act Insecticide Interference Claims Internet JMOL Joint Infringement Judgment As A Matter Of Law Kirtsaeng v. John Wiley & Sons Lanham Act License Agreements Life Technologies Corp v Promega Corp Limelight v Akamai Local Ordinance Marketing Method Claims Mootness Motion for Summary Judgment Motion to Vacate Mylan Pharmaceuticals Myriad Myriad-Mayo Nexus OPT Oracle PATENT Act Patent Cooperation Treaty Patent Expiration Patent Royalties Patented Medicine Prices Review Board (PMPRB) Pharmacies Pharmacist Phillips Standard Precedential Opinion Printed Publications Priority Patent Claims Privacy Concerns Product of Nature Doctrine Proposed Amendments Public Records Act Qui Tam Registration Reissue Patents Res Judicata Reversible Error Rules of Practice SEC Section 103 Section 5 Section 7 Sequenom Software Developers Split of Authority STEM Surveillance Tax Tribunal Technology Telecommunications Testimony Trademark Litigation Transfer of Venue TRO UK Unfair Competition Unfair or Deceptive Trade Practices US Fish and Wildlife Service USPTO Pilot Program Validity Visas Whistleblower Protection Policies Whistleblowers Wifi §315(e) Abbott Laboratories AbbVie Abuse of Process Action in Equity Additive Manufacturing Administrative Hearings Administrative Review Advanced Notice of Proposed Rulemaking (ANPRM) Adverse Employment Action Adverse Inference Instructions AFCP Affirmative Defenses Agency Deference Aglets Air Traffic Control Systems Airplane Accidents Amazon Amended Complaints Amgen v Hospira Analogous Art Anti-Retaliation Provisions Anticipatory Reference AOL Arbitration Arbitration Agreements Assumption of the Risk Attorney Generals Attorney Misconduct Audits Australian Patent Office Automobile Recall Automotive Industry Aviation Industry Bilski Biologics Price Competition and Innovation Act of 2009 Biomass Bitcoin Board of Patent Appeals Boehringer Books & Records Breach of Warranty Bylaws C-Suite Executives Cadence Pharmaceuticals Inc. Cancellation Rights Carbon Emissions Carve Out Provisions Cause of Action Accrual CCPs CEA Cease and Desist Cease and Desist Orders CEOs Certification Marks Certifications CFTC Chattel Chevron v NRDC Cipro Cisco Cisco v CommilUSA Civil Conspiracy Civil Service Reform Act CJEU Claim Limitations Claims Limitations Period Clean Water Act Clinical Trials Comment Period Commercial Use Communications Act of 1934 Compelled Speech Competition Authorities Complex Litigation Compliance Component Parts Doctrine Computer Fraud and Abuse Act (CFAA) Consent Consumer Watchdog Continuing Violation Theory Continuous Applications Conversion Copyright Litigation Covenant Not to Sue Credit Cards Crime Statistics Criminal Investigations Critical Infrastructure Sectors Customer-Loyalty Programs Daiichi Sankyo DaimlerChrysler v Bauman Data Collection Data Retention Data-Sharing DDR Holdings v Deceptive Intent Declaratory Relief Deed of Trust Default Judgment Defense Strategies Deferred Prosecution Agreements Denial of Certiorari Department of Revenue Depositions Design Patent Determination on Remand Diagnostic Tests Dickey-Wicker Amendment Dietary Supplements Digital Data Digital Downloads Direct Infringement Disability Disclosure Requirements Dismissal With Prejudice Disparagement Distribution Rules Dodd-Frank Domain Names Domestic Industry Requirement Dow Chemical DQSA Drug Compounding Drug Pricing Drug Safety DuPont Duty to Warn eBay eBay Test Economic Espionage Act Electronic Devices Eleventh Amendment Eli Lilly Employment Contract Energy Sector Enforcement Authority EPIC EPO Equal Protection Equitable Tolling Equivalency Determinations Ericsson Error At Law European Commission European Food Safety Authority (EFSA) Ex Parte Exclusion Orders Exclusive Licenses Exclusive Remedy Exclusivity Express Warranty Facebook Failure To Warn Fair Notice Fair Use Fairness Standard False Statements Farm Bureau FCPA FDCPA Federal Acquisition Regulations (FAR) Federal Jurisdiction Federal Pleading Requirements Federal Rule 12(b)(6) Federal v State Law Application Filing Requirements Final Action Financial Conduct Authority (FCA) First-to-File FOIA Follow-On Patent Petitions Ford Motor Foreign Corporations Foreign Patent Applications Foreign Students Form F-1 Former Employee Forum State France Fraud Fraud on the Court FRCP 19 FRCP 52(a)(2) Fresenius FTC v Wyndham Fund Managers Future Harm GAAP GAO Genetic Testing Genzyme Germany Global Standards Good Faith Goods or Services Goodyear Government Claims Government Investigations Greenhouse Gas Emissions gTLD Guilty Pleas H-1B Hana Bank Health Claims HELP Hewlett-Packard Highly-Skilled Workers Visa HIPAA Hitachi Honest Belief Defense Hospira HTC IBM ICANN Implied Warranties Importers Impression Products v Lexmark International In-Person Exam Incentives Individual Accountability Information Sharing Infrastructure Financing Inherent Disclosure Doctrine Initial Determination (ID) Insider Trading Intangible Property Intent Internal Controls International Litigation Internet of Things Internet Service Providers (ISPs) Interpretive Rule Interstate Commerce Intrinsic Test Investigational New Drug Application (IND) Investigations Investment Adviser Investment Advisers Act of 1940 Investment Company Act of 1940 IP Assignment Agreements IPEC Irreparable Harm Joinder Joint Enterprise Theory JPMorgan Chase Judicial Discretion Judicial Exception Jury Questions Kappos Kimble v Marvel Enterprises Kyle Bass Law Enforcement Lexmark Licensing Rights Licensing Rules Mandamus Petitions Mandatory Disclosure Rules Marketing Exclusivity Periods Markman Hearing Material Misstatements Materiality Medicaid Medicare Mensing Merck Minimum Contacts Misbranding Misrepresentation Mobile Devices Motion for JMOL Motion for Reconsideration Motion for Sanctions Motion Picture Industry Motion to Exclude Motion to Set Aside the Verdict Motion To Stay Motion to Transfer Motion to Withdraw Motions to Stay Proceedings Municipal Broadband Providers Municipalities Mutual Funds NAFTA Nanomaterials Nanosilver National Marine Fisheries Service Natural Resources Defense Council Nautilus Inc. v. Biosig Instruments Neither Admit Nor Deny Settlements New Guidance New York Times News Stories NFL NHTSA NIH Noerr-Pennington Doctrine Non-Profits Notice Provisions NPRM NRDC Nunc Pro Tunc NuVasive Obama Administration OCIE Octane Fitness v. ICON Oil States Energy Services v Greene's Energy Group OMB OMHA Omnicare Oracle v Google Order to Stay Out-of-State Companies Parallel Claims Part 107 Partial Summary Judgments Patent Amendments Patent Assertion Entities Patent Assignment and Transfer Agreement (PATA) Patent Examinations Patent Portfolios Patent Prosecution Highway Patentability Search Pay-For-Delay Penalties Personal Data Personalized Medicine Petition for Rulemaking Petitions for Review Pfizer PHSA Physicians Pleading Standards Pleadings PMNOC Regulations Police Policies and Procedures Prejudgment Interest Premarket Approval Applications Prescription Drug Coverage Pricing Requirements Priority Date Cutoff Privacy Policy Private Right of Action Private Sales Product Defects Product Exclusivity Professional Conferences Profits Proportionality Proposed Legislation Proposed Rules Public Comment Public Disclosure Public Employees Public Health Service Act Public Interest Public Notaries Public Officials Public Records Public Safety Purple Book Putative Class Actions RAND REACH Real Party in Interest Reasonable Person Test Reasonably Continuous Exercise of Diligence Standard Redesigned Products Redskins Remedies Renewable Energy Request For Information Required Documentation Research Funding Restraining Orders Retaliation Reverse Payment Settlement Agreements Revocation Risk Alert Roxane Laboratories Rule 10b-5 Sales Tax Same-Day Continuations Samsung Sarbanes-Oxley SAS Institute Inc v Matal SAS Institute Inc. v Lee SCA Hygiene Products Aktiebolag v First Quality Baby Products Science Advisory Board Scientific Research Scope of the Claim Seal SEC Examination Priorities Section 112 Section 16 Section 271 Section 706 Securities Securities Exchange Act Securities Fraud Settlement Settlement Conferences Sherley v Sebelius Shire Development v Watson Shot Clock Sound Recording Copyrights South Africa Sovereign Immunity Spoliation Sponsors Sprint Square Standard Essential Patents Standard of Proof Stanford University Stark Law State Medical Board Statutory Interpretation Strategic Enforcement Plan StreetView STRONG Patents Act Students Subject Matter Experts Subpoenas Sunrise Periods Supplemental Examination Suprema Supreme Court of Canada Swaps Takeda Pharmaceuticals Tariffs TC Heartland LLC v Kraft Foods Technical Errors Telehealth Terminal Disclaimer Termination Teva v Sandoz The Copyright Act The Patent Act The Slants Time Extensions Time-Barred Claims Title II Tolling Totality of Circumstances Test Toxic Substances Control Act (TSCA) Toyota Trading Platforms Transaction Privilege Tax Trespass Trial Court Orders Trial Preparation Trump Administration Unified Patent Court Unitary Patent US Army Corps of Engineers Utility Patents Vaccinations Vehicle Navigation Systems Vicarious Liability Virtual Currency Volkswagen Voluntary Withdrawal WARF Waters of the United States WEC Carolina v Miller White Collar Crimes Willful Blindness Wireless Industry Yates Memorandum